Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink

June 2, 2022

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink

Kayla E. Hanson et al.

Are COVID-19vaccines associated with Guillain-Barré syndrome (GBS)?

In this cohort study of surveillance data from the Vaccine Safety Datalink that included 15.1 million doses of COVID-19 vaccines, the unadjusted incidence rate of confirmed GBS in the 1 to 21 days after receiving the Ad.26.COV2.S (Janssen) vaccine was 32.4 per 100 000 person-years, which was significantly higher than the background rate of GBS. The unadjusted incidence rate of confirmed GBS in the 1 to 21 days after mRNA vaccines was 1.3 per 100 000 person-years, which did not differ from the background rate.

These findings suggest an increased risk of GBS after Ad.26.COV2.S vaccination.

Read the full article

covid-19 GBS Guillain-Barré

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink

You might also be interested in

Can Atmospheric Electricity Contribute to Pilots Collapsing from Blood Clots? How Does Electrically Responsive Hydrogel React under Increasing Voltage of Electrostatic Fields at High Altitude?

SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in Post-COVID-19

Spike Protein Accumulates in the Brain and Causes Infarcts, Bleeds, Inflammation - Pfizer & Moderna COVID-19 mRNA Vaccines Cause Severe Neurological Injuries

Latest articles

Mental Health Nutrition (Flyer)

BC Wrong for Forcing Unvaccinated Health Care Workers into Unemployment

The Link between Food and Mental Health

Food, Mood, and Brain Health: Implications for the Modern Clinician

Food and Mood: How Do Diet and Nutrition Affect Mental Wellbeing?

Is Lab-Grown Meat Healthy and Safe to Consume?

Become a member of CHA today!

Stay in touch

Thank you!

Thank you!